References 323 Chao , W. , and Olson , M. S. ( 1993 ). Platelet-activating factor: receptors and signal transduction . Biochem. 292 , 617 – 629 . Chen , H. , and Kahn , M. L. ( 2003 ). Reciprocal signaling by integrin and nonintegrin receptors during collagen activation <strong>of</strong> platelets . Mol. Cell. Biol. 23 , 4764 – 4777 . Cheryk , L. A. , Gentry , P. A. , and Tablin , F. ( 1997 ). Morphological characteristics <strong>of</strong> bovine platelets activated with platelet activating factor or thrombin . Comp. Haematol. Int. 1 , 88 – 94 . Chinn , D. R. , Dodds , W. J. , and Seicer , B. A. ( 1986 ). Prekallikrein deficiency in a dog . J. Am. Vet. Med. Assoc. 188 , 69 – 71 . Choi , E. S. , Hokom , M. M. , Chen , J. L. , Skrine , J. , Faust , J. , Nichol , J., and Hunt , P. (1996 ). The role <strong>of</strong> megakaryocyte growth and development factor in terminal stages <strong>of</strong> thrombopoiesis . Br. J. Haematol. 95 , 227 – 233 . Christopherson , P. , Insalaco , T. , van Santen , V. L. , Livesey , L. , Bourne , C. , and Boudreaux , M. K. ( 2006 ). Characterization <strong>of</strong> the cDNA encoding α IIb and β 3 in normal horses and two horses with Glanzmann thrombasthenia . Vet. Pathol. 43 , 78 – 82 . Collen , D. ( 1999 ). The plasminogen (fibrinolytic) system . Thromb. Haemost. 82 , 259 – 270 . Collet , J. P. , Montalescot , G. , Lesty , C. , and Weisel , J. W. ( 2002 ). A structural and dynamic investigation <strong>of</strong> the facilitating effect <strong>of</strong> glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots . Circ. Res. 90 , 428 – 434 . Cook , A. K. , Werner , L. L. , O’Neil , S. , Brooks , M. , and Feldman , B. F. ( 1993 ). Factor X deficiency in a Jack Russell terrier . Vet. Clin. Pathol. 22 , 68 – 71 . Coomber , B. L. , Mitchell , G. B. , Starr , A. E. , Minhas , K. , Tamblyn , A. , Shewan , P. E. , and Gentry , P. A. ( 2006 ). Clopidogrel induced suppression <strong>of</strong> bovine platelet activation in vitro and a preliminary study <strong>of</strong> its effect on development <strong>of</strong> Mannheimia haemolytica induced pneumonia . Vet. J. 171 , 126 – 134 . Cotter , S. M. , Brenner , R. M. , and Dodds , W. J. ( 1978 ). Hemophilia A in three unrelated cats . J. Am. Vet. Med. Assoc. 172 , 166 – 168 . Coughlin , P. B. ( 2005 a ). Antiplasmin. The forgotten serpin. FEBS J. 272 , 4852 – 4857 . Coughlin , S. R. ( 2005 b ). Protease-activated receptors in hemostasis, thrombosis and vascular biology . J. Thromb. Haemost. 3 , 1800 – 1814 . Couto , C. G. , Lara , A. , Iazbik , M. C. , and Brooks , M. B. ( 2006 ). Evaluation <strong>of</strong> platelet aggregation using a point-<strong>of</strong>-care instrument in retired racing greyhounds . J. Vet. Intern. Med. 20 , 365 – 370 . Cowan , S. M. , Bartges , J. W. , Gompf , R. E. , Hayes , J. R. , Moyers , T. D. , Snider , C. C. , Gerard , D. A. , Craft , R. M. , Muenchen , R. A. , and Carroll , R. C. ( 2004 ). Giant platelet disorder in the Cavalier King Charles spaniel. Exp. Hematol. 32 , 344 – 350 . Crawley , J. T. , Zanardelli , S. , Chion , C. K. , and Lane , D. A. ( 2007 ). The central role <strong>of</strong> thrombin in hemostasis . J. Thromb. Haemost. 5 ( suppl 1 ) , 95 – 1 01 . Cullen , P. , Rauterberg , J. , and Lorkowski , S. ( 2005 ). The pathogenesis <strong>of</strong> atherosclerosis . Handb. Exp. Pharmacol. 170 , 3 – 70 . Dahlback , B. ( 1995 ). The protein C anticoagulant system: inherited defects as basis for venous thrombosis . Thromb. Res. 77 , 1 – 43 . Dahlback , B. ( 2000 ). Blood coagulation . Lancet 355 , 1627 – 1632 . Dallap , B. L. , Dolente , B. , and Boston , R. ( 2003 ). Coagulation pr<strong>of</strong>iles in 27 horses with large colon volvulus . J. Vet. Emerg. Crit. Care, 13 , 215 – 225 . Dangelmaier , C. , Jin , J. , Smith , J. B. , and Kunapuli , S. P. ( 2001 ). Potentiation <strong>of</strong> thromboxane A 2 -induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway . Thromb. Haemost. 85 , 341 – 348 . Darien , B. J. (2000a ). Acquired coagulopathy V: Thrombosis . In “ Schalm’s Veterinary Hematology ” ( B. F. Feldman , J. G. Zinkl , and N. C. Jain , Eds.) , 5th ed . , pp. 574 – 580 . Lippincott Williams and Wilkins , Philadelphia . Darien , B. J. ( 2000 b ). Fibrinolytic system . In “ Schalm’s Veterinary Hematology ” ( B. F. Feldman , J. G. Zinkl , and N. C. Jain , Eds.) , 5th ed . , pp. 544 – 548 . Lippincott Williams and Wilkins , Philadelphia . Day , S. M. , Reeve , J. L. , Pedersen , B. , Farris , D. M. , Meyers , D. D. , Im , M. , Wakefield , T. W. , Mackman , N. , and Fay , W. P. ( 2005 ). Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall . Blood 105 , 192 – 198 . DeCandia , E. , Hall , S. W. , and Rutella , S. ( 2001 ). Binding <strong>of</strong> thrombin to glycoprotein Ib accelerates the hydrolysis <strong>of</strong> Par-1 on intact platelets . J. Biol. Chem. 276 , 4692 – 4698 . deGroot , P. G. , and Sixma , J. J. ( 1996 ). Regulation <strong>of</strong> platelet-rich thrombus formation by the endothelium . In “ Vascular Control <strong>of</strong> Hemostasis ” ( V. M. vanHinsbergh , Ed.) , pp. 127 – 146 . Harwood Academic Publishers , Amsterdam . de Jonge , E. , Dekkers , P. E. , Creasey , A. A. , Hack , C. E. , Paulson , S. K. , Karim , A. , Kesecioglu , J. , Levi , M. , van Deventer , S. J. , and van Der Poll , T. ( 2000 ). Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia . Blood 95 , 1124 – 1129 . Denis , C. V. , and Wagner , D. D. ( 1999 ). Insights from von Willebrand disease animal models . Cell. Mol. Life Sci. 56 , 977 – 990 . Deniz , A. , Mischke , R. , and Nolte , I. ( 1995 ). Applicability <strong>of</strong> activated partial thromboplastin time (APTT) as a screening test <strong>of</strong> milk to medium deficiencies <strong>of</strong> coagulation factors in cats . Dtsch. Tierarztl. Wochenschr. 102 , 206 – 208 . Di Cera , E. ( 2003 ). Thrombin interactions . Chest 124 , 11S – 17S . Dillon , A. R. , and Boudreaux , M. K. (1988 ). Combined factor IX and XII deficiencies in a family <strong>of</strong> cats . J. Am. Vet. Med. Assoc. 193 , 833 –834 . Dobrovolsky , A. B. , and Titaeva , E. V. ( 2002 ). The fibrinolysis system: regulation <strong>of</strong> activity and physiological function <strong>of</strong> its main components . <strong>Biochemistry</strong> (Moscow) 67 , 99 – 108 . Dodds , W. J. ( 1973 ). Canine factor X (Stuart-Prower factor) deficiency . J. Lab. Clin. Med. 82 , 560 – 566 . Dodds , W. J. ( 1978 ). Platelet function in animals: species specificities . In “ Platelets: A Multidisciplinary Approach ” ( G. deGaetano and S. Garattinin , Eds.) , pp. 45 – 59 . Raven Press , New York . Dodds , W. J. ( 1997 ). Hemostasis . In “ <strong>Clinical</strong> <strong>Biochemistry</strong> <strong>of</strong> <strong>Domestic</strong> <strong>Animals</strong> ” ( J. J. Kaneko , J. W. Harvey , and M. L. Bruss , Eds.) , 5th ed . , pp. 241 – 283 . Academic Press , San Diego, CA . Dodds , W. J. ( 2000 ). Other hereditary coagulopathies . In “ Schalm’s Veterinary Hematology ” ( B. F. Feldman , J. G. Zinkl , and N. C. Jain , Eds.) , 5th ed . , pp. 1030 – 1036 . Lippincott Williams and Wilkins , Philadelphia . Dodds , W. J. , and Kull , J. E. ( 1971 ). Canine factor XI (plasma thromboplastin antecedent) deficiency . J. Lab. Clin. Med. 78 , 746 – 752 . Dodds , W. J. , Moynihan , A. C. , Fisher , T. M. , and Trauner , D. B. ( 1981 ). The frequencies <strong>of</strong> inherited blood and eye diseases as determined by genetic screening programs . J. Am. Anim. Hosp. Assoc. 17 , 697 – 704 . Dolente , B. A. , Wilkins , P. A. , and Boston , R. C. ( 2002 ). Clinicopathologic evidence <strong>of</strong> disseminated intravascular coagulation in horses with acute colitis . J. Am. Vet. Med. Assoc. 220 , 1034 – 1038 . Donahue , S. M. , and Otto , C. M. ( 2005 ). Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis . J. Vet. Emerg. Crit. Care. 15 , 9 – 16 . Doshi , S. , and Marmur , J. D. ( 2002 ). Evolving role <strong>of</strong> tissue factor and its pathway inhibitor . Crit. Care Med. 30 , S241 – S250 .
324 Chapter | 10 Hemostasis Dowd , P. , Ham , S. W. , Naganathan , S. , and Hershline , R. ( 1995 a ). The mechanism <strong>of</strong> action <strong>of</strong> vitamin K . Ann. Rev. in Nut. 15 , 419 – 440 . Dowd , P. , Hershline , R. , Ham , S. W. , and Naganathan , S. ( 1995 b ). Vitamin K and energy transduction: a base strength amplification mechanism . Science 269 , 1684 – 1691 . Duggan , M. J. , Dimichele , D. M. , Christian , M. J. , Fink , L. M. , and Hathaway , W. E. ( 1987 ). Collagen-binding <strong>of</strong> von Willebrand’s factor antigen in the classification <strong>of</strong> von Willebrand’s disease . Am. J. Clin. Pathol. 88 , 97 – 102 . Dugina , T. N. , Kiseleva , E. V. , Chistove , I. V. , Umarova , B. A. , and Strukova , S. M. ( 2002 ). Receptors <strong>of</strong> the PAR family as a link between blood, coagulation and inflammation . Biochem. 67 , 65 – 74 . DuVall , M. D. , Murphy , M. J. , Ray , A. C. , and Reagor , J. C. ( 1989 ). Case studies on second-generation anticoagulant rodenticide toxicities in nontarget species . J. Vet. Diagn. Invest. 1 , 66 – 68 . Edens , L. M. , Morris , D. D. , Prasse , K. W. , and Anver , M. R. ( 1993 ). Hypercoagulable state associated with a deficiency <strong>of</strong> protein C in a thoroughbred colt . J. Vet. Intern. Med. 7 , 190 – 193 . Edmead , C. E. , Crosby , D. A. , Southcott , M. , and Poole , A. W. ( 1999 ). Thrombin-induced association <strong>of</strong> SHP-2 with multiple tyrosinephosphorylated proteins in human platelets . FEBS Lett. 459 , 27 – 32 . Escolar , G. , and White , J. G. ( 1991 ). The platelet open canalicular system: a final common pathway . Blood Cells 17 , 467 – 485 . Esmon , C. T. ( 2003 ). The protein C pathway . Chest 124 , 26S – 32S . Esmon , C. T. ( 2005 ). The interactions between inflammation and coagulation . Br. J. Haematol. 131 , 417 – 430 . Evans , G. O. , and Flynn , R. M. ( 1992 ). Activated partial thromboplastin time measurements in citrated canine plasma . J. Comp. Pathol. 106 , 79 – 82 . Evans , J. P. , Brinkhous , K. M. , Brayer , G. D. , Reisner , H. M. , and High , K. A. (1989 ). Canine hemophilia B resulting from a point mutation with unusual consequences . Proc. Natl. Acad. Sci. USA, 86 , 10095 –10099 . Ewenstein , B. ( 1997 ). Von Willebrand’s disease . Annu. Rev. Med. 48 , 525 – 542 . Faust , S. N. , Levin , M. , Harrison , O. B. , Goldin , R. D. , Lockhart , M. S. , Kondaveeti , S. , Laszik , Z. , Esmon , C. T. , and Heyderman , R. S. ( 2001 ). Dysfunction <strong>of</strong> endothelial protein C activation in severe meningococcal sepsis . N. Engl. J. Med. 345 , 408 – 416 . Favaloro , E. J. ( 2000 ). Detection <strong>of</strong> von Willebrand disorder and identification <strong>of</strong> qualitative von Willebrand factor defects: direct comparison <strong>of</strong> commercial ELISA-based von Willebrand factor activity options . Am. J. Clin. Pathol. 114 , 608 – 618 . Favaloro , E. J. , Facey , D. , and Henniker , A. ( 1999 ). Use <strong>of</strong> a novel platelet function analyzer (PFA-100) with a high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand’s disease and other disorders . Am. J. Hematol. 62 , 165 – 174 . Favaloro , E. J. , Grispo , L. , and Koutts , J. ( 1991 ). Development <strong>of</strong> a simple collagen based ELISA assay aids in the diagnosis <strong>of</strong>, and permits sensitive discrimination between type I and type II, von Willebrand’s disease . Blood Coagul. Fibrinolysis 2 , 285 – 291 . Fecteau , G. , Zinkl , J. G. , Smith , B. P. , O’Neil , S. , Smith , S. , and Klopfer , S. ( 1997 ). Dysfibrinogenemia or afibrinogenemia in a Border Leicester lamb . Can. Vet. J. 38 , 443 – 444 . Feil , R. , Lohmann , S. M. , deJonge , H. , Walter , U. , and H<strong>of</strong>mann , F. ( 2003 ). Cyclic GMP-dependent protein kinases and the cardiovascular system . Circ. Res. 93 , 907 – 916 . Feldman , B. F. , Soares , M. A. , Kitchell , B. E. , Brown , C. C. , and O’Neill , S. ( 1983 ). Hemorrhage in a cat caused by inhibition <strong>of</strong> factor XI (plasma thromboplastin antecedent) . J. Am. Vet. Med. Assoc. 182 , 589 – 591 . Flaumenhaft , R. ( 2003 ). Molecular basis <strong>of</strong> platelet granule secretion . Arterioscler. Thromb. Vasc. Biol. 23 , 1152 – 1160 . Fogh , J. M. ( 1988 ). A study <strong>of</strong> hemophilia in German shepherd dogs in Denmark . Vet. Clin. North Am. Small Anim. Pract. 18 , 245 – 254 . Fogh , J. M. , and Fogh , I. T. ( 1988 ). Inherited coagulation disorders . Vet. Clin. North Am. Small Anim. Pract. 18 , 231 – 243 . Forbes , C. D. , Thomson , C. , Prentice , C. R. M. , and McNicol , G. P. ( 1973 ). Experimental warfarin poisoning in the dog . J. Comp. Pathol. 83 , 173 – 180 . Franchini , M. , Lippi , G. , and Manzato , F. ( 2006 ). Recent acquisitions in the pathophysiology, diagnosis and treatment <strong>of</strong> disseminated intravascular coagulation . Thrombosis J. 4 , 4 . Franchini , M. , Veneri , D. , and Lippi , G. ( 2007 ). Inflammation and hemostasis: a bidirectional interaction . Clin. Lab. 53 , 63 – 67 . Frojmovic , M. M. , Wong , T. , and Searcy , G. P. ( 1996 ). Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression <strong>of</strong> GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation . Thromb. Haemost. 76 , 1047 – 1052 . Frost , C. L. , Naude , R. J. , and Muramoto , K. (2002 ). Ostrich antithrombin III: kinetics and mechanism <strong>of</strong> inhibition <strong>of</strong> ostrich thrombin . Int. J. Biochem. Cell Biol. 34 , 1164 – 1171 . Fuchs , H. E. , and Pizzo , S. V. ( 1983 ). The regulation <strong>of</strong> factor Xa in vitro in human and mouse plasma and in vivo in mouse. The role <strong>of</strong> the endothelium and the plasma proteinase inhibitors . J. Clin. Invest. 72 , 2041 – 2049 . Furlanello , T. , Caldin , M. , Stocco , A. , Tudone , E. , Tranquillo , V. , Lubas , G. , and Solano-Gallego , L. ( 2006 ). Stability <strong>of</strong> stored canine plasma for hemostasis testing . Vet. Clin. Pathol. 35 , 204 – 207 . Gaal , T. , Halmay , D. , Kocsis , R. , and Abonyi-Toth , Z. (2007 ). Evaluation <strong>of</strong> the effect <strong>of</strong> ketopr<strong>of</strong>en and carpr<strong>of</strong>en on platelet function in dogs studied by PFA-100 point-<strong>of</strong>-care analyser . Acta Vet. Hung. 55 , 287 –294 . Gachet , C. ( 2001 ). ADP receptors <strong>of</strong> platelets and their inhibition . Thromb. Haemost. 86 , 222 – 232 . Gailani , D. ( 2000 ). Activation <strong>of</strong> factor IX by factor IXa . Trends Cardiovasc. Med. 10 , 198 – 204 . Gailani , D. , and Broze , G. J. ( 1991 ). Factor XI activation in a revised model <strong>of</strong> blood coagulation . Science 253 , 909 – 912 . Gando , S. ( 2001 ). Disseminated intravascular coagulation in trauma patients . Semin. Thromb. Haemost. 27 , 585 – 592 . Gear , A. R. , and Camerini , D. ( 2003 ). Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense . Microcirculation 10 , 335 – 350 . Gentry , P. A. ( 1992 ). The mammalian blood platelets: its role in haemostasis, inflammation and tissue repair . J. Comp. Pathol. 107 , 243 – 270 . Gentry , P. A. ( 2000 a ). Factor XI deficiency . In “ Schalm’s Veterinary Hematology ” ( B. F. Feldman , J. G. Zinkl , and N. C. Jain , Eds.) , 5th ed . , pp. 1037 – 1041 . Lippincott Williams and Wilkins , Philadelphia . Gentry , P. A. ( 2000 b ). Platelet biology . In “ Schalm’s Veterinary Hematology ” ( B. F. Feldman , J. G. Zinkl , and N. C. Jain , Eds.) , 5th ed . , pp. 459 – 466 . Lippincott Williams and Wilkins , Philadelphia . Gentry , P. A. ( 2004 ). Comparative aspects <strong>of</strong> blood coagulation . Vet. J. 168 , 238 – 251 . Gentry , P. A. , Crane , S. , and Lotz , F. ( 1975 ). Factor XI (plasma thromboplastin antecedent) deficiency in cattle . Can. Vet. J. 16 , 160 – 162 . Gentry , P. A. , Niemuller , C. , Ross , M. L. , and Liptrap , R. M. ( 1989 ). Platelet aggregation in the Asian elephant is not dependent on thromboxane B 2 production . Comp. Biochem. Physiol. 94A , 47 – 51 . Gentry , P. A. , and Nyarko , K. ( 2000 ). Platelet lipids and prostaglandins . In “ Schalm’s Veterinary Hematology ” ( B. F. Feldman , J. G. Zinkl , and
- Page 1 and 2:
Preface It has been more than a dec
- Page 3 and 4:
viii Contributors Björn P. Meij (5
- Page 5 and 6:
2 Chapter | 1 Concepts of Normality
- Page 7 and 8:
4 Chapter | 1 Concepts of Normality
- Page 9 and 10:
6 Chapter | 1 Concepts of Normality
- Page 11 and 12:
8 Chapter | 1 Concepts of Normality
- Page 13 and 14:
10 Chapter | 1 Concepts of Normalit
- Page 15 and 16:
12 Chapter | 1 Concepts of Normalit
- Page 17 and 18:
14 Chapter | 1 Concepts of Normalit
- Page 19 and 20:
16 Chapter | 1 Concepts of Normalit
- Page 21 and 22:
18 Chapter | 1 Concepts of Normalit
- Page 23 and 24:
20 Chapter | 1 Concepts of Normalit
- Page 25 and 26:
22 Chapter | 1 Concepts of Normalit
- Page 27 and 28:
24 Chapter | 1 Concepts of Normalit
- Page 29 and 30:
Chapter 2 Comparative Medical Genet
- Page 31 and 32:
I. Introduction 29 Green Red Green
- Page 33 and 34:
I. Introduction 31 A1 genetic map d
- Page 35 and 36:
I. Introduction 33 of genomes of va
- Page 38 and 39:
36 Chapter | 2 Comparative Medical
- Page 40 and 41:
38 Chapter | 2 Comparative Medical
- Page 42 and 43:
40 Chapter | 2 Comparative Medical
- Page 44 and 45:
42 Chapter | 2 Comparative Medical
- Page 46 and 47:
44 Chapter | 2 Comparative Medical
- Page 48 and 49:
46 Chapter | 3 Carbohydrate Metabol
- Page 50 and 51:
48 Chapter | 3 Carbohydrate Metabol
- Page 52 and 53:
50 Chapter | 3 Carbohydrate Metabol
- Page 54 and 55:
52 Chapter | 3 Carbohydrate Metabol
- Page 56 and 57:
54 Chapter | 3 Carbohydrate Metabol
- Page 58 and 59:
56 Chapter | 3 Carbohydrate Metabol
- Page 60 and 61:
58 Chapter | 3 Carbohydrate Metabol
- Page 62 and 63:
60 Chapter | 3 Carbohydrate Metabol
- Page 64 and 65:
62 Chapter | 3 Carbohydrate Metabol
- Page 66 and 67:
64 Chapter | 3 Carbohydrate Metabol
- Page 68 and 69:
66 Chapter | 3 Carbohydrate Metabol
- Page 71 and 72:
IX. Disorders of Carbohydrate Metab
- Page 73 and 74:
IX. Disorders of Carbohydrate Metab
- Page 75 and 76:
IX. Disorders of Carbohydrate Metab
- Page 77 and 78:
X. Disorders of Ruminants Associate
- Page 79 and 80:
X. Disorders of Ruminants Associate
- Page 81 and 82:
References 79 Kaneko , J. J. , Luic
- Page 83 and 84:
Chapter 4 Lipids and Ketones Michae
- Page 85 and 86:
II. Long Chain Fatty Acids 83 FIGUR
- Page 87 and 88:
II. Long Chain Fatty Acids 85 Plasm
- Page 89 and 90:
IV. Phospholipids 87 The regulation
- Page 91 and 92:
V. Cholesterol 89 V. CHOLESTEROL A.
- Page 93 and 94:
VI. Lipoproteins 91 TABLE 4-1 Compo
- Page 95 and 96:
VI. Lipoproteins 93 TABLE 4-2 Apoli
- Page 98 and 99:
96 Chapter | 4 Lipids and Ketones B
- Page 100 and 101:
98 Chapter | 4 Lipids and Ketones
- Page 102 and 103:
100 Chapter | 4 Lipids and Ketones
- Page 104 and 105:
102 Chapter | 4 Lipids and Ketones
- Page 106 and 107:
104 Chapter | 4 Lipids and Ketones
- Page 108 and 109:
106 Chapter | 4 Lipids and Ketones
- Page 110 and 111:
108 Chapter | 4 Lipids and Ketones
- Page 112 and 113:
110 Chapter | 4 Lipids and Ketones
- Page 114 and 115:
112 Chapter | 4 Lipids and Ketones
- Page 116 and 117:
114 Chapter | 4 Lipids and Ketones
- Page 118 and 119:
Chapter 5 Proteins, Proteomics, and
- Page 120 and 121:
III. Metabolism of Proteins 119 C .
- Page 122 and 123:
IV. Plasma Proteins 121 NH 4 HCO
- Page 124 and 125:
V. Methodology 123 molecule. The gl
- Page 126 and 127:
V. Methodology 125 has occurred wil
- Page 128 and 129:
V. Methodology 127 Although attempt
- Page 130 and 131:
V. Methodology 129 kD 94 67 43 2 2
- Page 132 and 133:
V. Methodology 131 D . Specific Pro
- Page 134 and 135:
VI. Normal Plasma and Serum Protein
- Page 136 and 137:
VI. Normal Plasma and Serum Protein
- Page 138 and 139:
VI. Normal Plasma and Serum Protein
- Page 140 and 141:
VI. Normal Plasma and Serum Protein
- Page 142 and 143:
VI. Normal Plasma and Serum Protein
- Page 144 and 145:
VII. Interpretation of Serum Protei
- Page 146 and 147:
VII. Interpretation of Serum Protei
- Page 148 and 149:
VII. Interpretation of Serum Protei
- Page 150 and 151:
References 149 Andersson , M. , Ste
- Page 152 and 153:
References 151 response of haptoglo
- Page 154 and 155:
References 153 dogs with metastasiz
- Page 156 and 157:
References 155 Watson , T. D. G. (
- Page 158:
158 Chapter | 6 Clinical Veterinary
- Page 163 and 164:
V. Methods for Evaluation of the Im
- Page 165 and 166:
V. Methods for Evaluation of the Im
- Page 167 and 168:
V. Methods for Evaluation of the Im
- Page 169:
VI. Laboratory Diagnosis of Disease
- Page 173 and 174:
Chapter 7 The Erythrocyte: Physiolo
- Page 175 and 176:
II. Hematopoiesis 175 progenitor ce
- Page 177 and 178:
III. Developing Erythroid Cells 177
- Page 179 and 180:
III. Developing Erythroid Cells 179
- Page 181 and 182:
III. Developing Erythroid Cells 181
- Page 183 and 184:
III. Developing Erythroid Cells 183
- Page 185 and 186:
IV. Mature RBC 185 immune-mediated
- Page 187 and 188:
IV. Mature RBC 187 TABLE 7-3 Erythr
- Page 189 and 190:
IV. Mature RBC 189 TABLE 7.5 Erythr
- Page 191 and 192:
IV. Mature RBC 191 Echinocyte forma
- Page 193 and 194:
IV. Mature RBC 193 Pig RBC isoantig
- Page 195 and 196:
IV. Mature RBC 195 occurs in chicke
- Page 197 and 198:
IV. Mature RBC 197 inorganic phosph
- Page 199 and 200:
IV. Mature RBC 199 (a) FIGURE 7-6 T
- Page 201 and 202:
IV. Mature RBC 201 RBC 2,3DPG incre
- Page 203 and 204:
IV. Mature RBC 203 mechanisms would
- Page 205 and 206:
IV. Mature RBC 205 released during
- Page 207 and 208:
IV. Mature RBC 207 reduced by ascor
- Page 209 and 210:
V. Determinants of RBC Survival 209
- Page 211 and 212:
V. Determinants of RBC Survival 211
- Page 213 and 214:
VI. Inherited Disorders of RBCs 213
- Page 215 and 216:
VI. Inherited Disorders of RBCs 215
- Page 217 and 218:
VI. Inherited Disorders of RBCs 217
- Page 219 and 220:
described in people. They include a
- Page 221 and 222:
References 221 Boas , F. E. , Forma
- Page 223 and 224:
References 223 Della Rovere , F. ,
- Page 225 and 226:
References 225 Gedde , M. M. , Davi
- Page 227 and 228:
References 227 phosphofructokinase-
- Page 229 and 230:
References 229 Knight , A. P. , Las
- Page 231 and 232:
References 231 Martinovich , D. , a
- Page 233 and 234:
References 233 Pearson , W. , Boerm
- Page 235 and 236:
References 235 Shadduck , R. K. ( 1
- Page 237 and 238:
References 237 Tennant , B. , Dill
- Page 239 and 240:
References 239 Williams , D. M. , L
- Page 241 and 242:
Chapter 8 Porphyrins and the Porphy
- Page 243 and 244:
II. Porphyrins 243 two vinyl groups
- Page 245 and 246:
II. Porphyrins 245 TABLE 8-2 Nomenc
- Page 247 and 248:
IV. Porphyrias 247 6. Uroporphyrins
- Page 249 and 250:
IV. Porphyrias 249 i . Urine It is
- Page 251 and 252:
IV. Porphyrias 251 to localize the
- Page 253 and 254:
IV. Porphyrias 253 FIGURE 8-6 Metab
- Page 255 and 256:
IV. Porphyrias 255 estrogens. The d
- Page 257 and 258:
References 257 and hexachlorobenzen
- Page 259 and 260:
Chapter 9 Iron Metabolism and Its D
- Page 261 and 262:
II. Iron Distribution 261 plasma of
- Page 263 and 264:
IV. Plasma Iron Transport 263 pathw
- Page 265 and 266:
VI. Iron Metabolism in Cells 265 of
- Page 267 and 268:
VI. Iron Metabolism in Cells 267 in
- Page 269 and 270:
VII. Tests for Evaluating Iron Meta
- Page 271 and 272: VII. Tests for Evaluating Iron Meta
- Page 273 and 274: VIII. Disorders of Iron Metabolism
- Page 275 and 276: VIII. Disorders of Iron Metabolism
- Page 277 and 278: VIII. Disorders of Iron Metabolism
- Page 279 and 280: References 279 ( Norrdin et al ., 2
- Page 281 and 282: References 281 Fresco , R. ( 1981 )
- Page 283 and 284: References 283 Moore , C. V. , Duba
- Page 285 and 286: References 285 Weiden , P. L. , Hac
- Page 287 and 288: 288 Chapter | 10 Hemostasis TABLE 1
- Page 289 and 290: 290 Chapter | 10 Hemostasis TABLE 1
- Page 291 and 292: 292 Chapter | 10 Hemostasis The pro
- Page 293 and 294: 294 Chapter | 10 Hemostasis exhibit
- Page 295 and 296: 296 Chapter | 10 Hemostasis TABLE 1
- Page 297 and 298: 298 Chapter | 10 Hemostasis that is
- Page 299 and 300: 300 Chapter | 10 Hemostasis TABLE 1
- Page 301 and 302: 302 Chapter | 10 Hemostasis However
- Page 303 and 304: 304 Chapter | 10 Hemostasis 2. Comp
- Page 305 and 306: 306 Chapter | 10 Hemostasis is a re
- Page 307 and 308: 308 Chapter | 10 Hemostasis 2. Asse
- Page 309 and 310: 310 Chapter | 10 Hemostasis necessi
- Page 311 and 312: 312 Chapter | 10 Hemostasis disease
- Page 313 and 314: 314 Chapter | 10 Hemostasis concent
- Page 315 and 316: 316 Chapter | 10 Hemostasis the rol
- Page 317 and 318: 318 Chapter | 10 Hemostasis proport
- Page 319 and 320: 320 Chapter | 10 Hemostasis a consi
- Page 321: 322 Chapter | 10 Hemostasis Bakhtia
- Page 325 and 326: 326 Chapter | 10 Hemostasis Kier ,
- Page 327 and 328: 328 Chapter | 10 Hemostasis Nielsen
- Page 329 and 330: 330 Chapter | 10 Hemostasis Tablin
- Page 331 and 332: 332 Chapter | 11 Neutrophil Functio
- Page 333 and 334: 334 Chapter | 11 Neutrophil Functio
- Page 335 and 336: 336 Chapter | 11 Neutrophil Functio
- Page 337 and 338: 338 Chapter | 11 Neutrophil Functio
- Page 339 and 340: 340 Chapter | 11 Neutrophil Functio
- Page 341 and 342: 342 Chapter | 11 Neutrophil Functio
- Page 343 and 344: 344 Chapter | 11 Neutrophil Functio
- Page 345 and 346: 346 Chapter | 11 Neutrophil Functio
- Page 347 and 348: 348 Chapter | 11 Neutrophil Functio
- Page 349 and 350: 350 Chapter | 11 Neutrophil Functio
- Page 351 and 352: 352 Chapter | 12 Diagnostic Enzymol
- Page 353 and 354: 354 Chapter | 12 Diagnostic Enzymol
- Page 355 and 356: 356 Chapter | 12 Diagnostic Enzymol
- Page 357 and 358: 358 Chapter | 12 Diagnostic Enzymol
- Page 359 and 360: 360 Chapter | 12 Diagnostic Enzymol
- Page 361 and 362: 362 Chapter | 12 Diagnostic Enzymol
- Page 363 and 364: 364 Chapter | 12 Diagnostic Enzymol
- Page 365 and 366: 366 Chapter | 12 Diagnostic Enzymol
- Page 367 and 368: 368 Chapter | 12 Diagnostic Enzymol
- Page 369 and 370: 370 Chapter | 12 Diagnostic Enzymol
- Page 371 and 372: 372 Chapter | 12 Diagnostic Enzymol
- Page 373 and 374:
374 Chapter | 12 Diagnostic Enzymol
- Page 375 and 376:
376 Chapter | 12 Diagnostic Enzymol
- Page 377 and 378:
378 Chapter | 12 Diagnostic Enzymol
- Page 379 and 380:
380 Chapter | 13 Hepatic Function L
- Page 381 and 382:
382 Chapter | 13 Hepatic Function e
- Page 383 and 384:
384 Chapter | 13 Hepatic Function p
- Page 385 and 386:
386 Chapter | 13 Hepatic Function m
- Page 387 and 388:
388 Chapter | 13 Hepatic Function s
- Page 389 and 390:
390 Chapter | 13 Hepatic Function f
- Page 391 and 392:
392 Chapter | 13 Hepatic Function T
- Page 393 and 394:
394 Chapter | 13 Hepatic Function 2
- Page 395 and 396:
396 Chapter | 13 Hepatic Function u
- Page 397 and 398:
398 Chapter | 13 Hepatic Function 2
- Page 399 and 400:
400 Chapter | 13 Hepatic Function c
- Page 401 and 402:
402 Chapter | 13 Hepatic Function F
- Page 403 and 404:
404 Chapter | 13 Hepatic Function A
- Page 405 and 406:
406 Chapter | 13 Hepatic Function E
- Page 407 and 408:
408 Chapter | 13 Hepatic Function K
- Page 409 and 410:
410 Chapter | 13 Hepatic Function R
- Page 411 and 412:
412 Chapter | 13 Hepatic Function W
- Page 413 and 414:
414 Chapter | 14 Gastrointestinal F
- Page 415 and 416:
416 Chapter | 14 Gastrointestinal F
- Page 417 and 418:
418 Chapter | 14 Gastrointestinal F
- Page 419 and 420:
420 Chapter | 14 Gastrointestinal F
- Page 421 and 422:
422 Chapter | 14 Gastrointestinal F
- Page 423 and 424:
424 Chapter | 14 Gastrointestinal F
- Page 425 and 426:
426 Chapter | 14 Gastrointestinal F
- Page 427 and 428:
428 Chapter | 14 Gastrointestinal F
- Page 429 and 430:
430 Chapter | 14 Gastrointestinal F
- Page 431 and 432:
432 Chapter | 14 Gastrointestinal F
- Page 433 and 434:
434 Chapter | 14 Gastrointestinal F
- Page 435 and 436:
436 Chapter | 14 Gastrointestinal F
- Page 437 and 438:
438 Chapter | 14 Gastrointestinal F
- Page 439 and 440:
440 Chapter | 14 Gastrointestinal F
- Page 441 and 442:
442 Chapter | 14 Gastrointestinal F
- Page 443 and 444:
444 Chapter | 14 Gastrointestinal F
- Page 445 and 446:
446 Chapter | 14 Gastrointestinal F
- Page 447 and 448:
448 Chapter | 14 Gastrointestinal F
- Page 449 and 450:
450 Chapter | 14 Gastrointestinal F
- Page 451 and 452:
452 Chapter | 14 Gastrointestinal F
- Page 453 and 454:
454 Chapter | 14 Gastrointestinal F
- Page 455 and 456:
456 Chapter | 14 Gastrointestinal F
- Page 457 and 458:
Chapter 15 Skeletal Muscle Function
- Page 459 and 460:
II. Specialization of the Sarcolemm
- Page 461 and 462:
II. Specialization of the Sarcolemm
- Page 463 and 464:
III. Heterogeneity of Skeletal Musc
- Page 465 and 466:
III. Heterogeneity of Skeletal Musc
- Page 467 and 468:
V. Exercise and Adaptations to Trai
- Page 469 and 470:
VI. Diagnostic Laboratory Methods f
- Page 471 and 472:
VI. Diagnostic Laboratory Methods f
- Page 473 and 474:
IX. Selected Neuromuscular Disorder
- Page 475 and 476:
IX. Selected Neuromuscular Disorder
- Page 477 and 478:
References 479 and, recently, there
- Page 479 and 480:
References 481 Engel , A. G. ( 2004
- Page 481 and 482:
References 483 Paciello , O. , Maio
- Page 483 and 484:
Chapter 16 Kidney Function and Dama
- Page 485 and 486:
II. Kidney Morphology and Function
- Page 487 and 488:
II. Kidney Morphology and Function
- Page 489 and 490:
III. Tests of Kidney Function 491 (
- Page 491 and 492:
III. Tests of Kidney Function 493 T
- Page 493 and 494:
III. Tests of Kidney Function 495 B
- Page 495 and 496:
6 5 4 3 2 1 0 Dog Cat Equine Cattle
- Page 497 and 498:
III. Tests of Kidney Function 499 d
- Page 499 and 500:
IV. Tests of Kidney Damage 501 1000
- Page 501 and 502:
IV. Tests of Kidney Damage 503 and
- Page 503 and 504:
IV. Tests of Kidney Damage 505 Enzy
- Page 505 and 506:
V. Biochemical Changes in Kidney Di
- Page 507 and 508:
V. Biochemical Changes in Kidney Di
- Page 509 and 510:
References 511 were reported to occ
- Page 511 and 512:
References 513 Bovee , K. C. ( 1969
- Page 513 and 514:
References 515 Deguchi , E. , and A
- Page 515 and 516:
References 517 Fleming , S. A. , Hu
- Page 517 and 518:
References 519 Harvey , D. G. ( 197
- Page 519 and 520:
References 521 Kühl , S. , Mischke
- Page 521 and 522:
References 523 creatinine measureme
- Page 523 and 524:
References 525 Reusch , C. , Vochez
- Page 525 and 526:
References 527 Terry , R. , Hawkins
- Page 527 and 528:
Chapter 17 Fluid, Electrolyte, and
- Page 530 and 531:
532 Chapter | 17 Fluid, Electrolyte
- Page 534 and 535:
536 Chapter | 17 Fluid, Electrolyte
- Page 536 and 537:
538 Chapter | 17 Fluid, Electrolyte
- Page 538 and 539:
540 Chapter | 17 Fluid, Electrolyte
- Page 540 and 541:
542 Chapter | 17 Fluid, Electrolyte
- Page 542 and 543:
544 Chapter | 17 Fluid, Electrolyte
- Page 544 and 545:
546 Chapter | 17 Fluid, Electrolyte
- Page 546 and 547:
548 Chapter | 17 Fluid, Electrolyte
- Page 548 and 549:
550 Chapter | 17 Fluid, Electrolyte
- Page 551 and 552:
VIII. Clinicopathological Indicator
- Page 553 and 554:
References 555 plasma water, electr
- Page 555 and 556:
References 557 Krzywanek , H. ( 197
- Page 557 and 558:
References 559 Strombeck , D. R. (1
- Page 559 and 560:
562 Chapter | 18 Pituitary Function
- Page 561 and 562:
564 Chapter | 18 Pituitary Function
- Page 563 and 564:
566 Chapter | 18 Pituitary Function
- Page 565 and 566:
568 Chapter | 18 Pituitary Function
- Page 567 and 568:
570 Chapter | 18 Pituitary Function
- Page 569 and 570:
572 Chapter | 18 Pituitary Function
- Page 571 and 572:
574 Chapter | 18 Pituitary Function
- Page 573 and 574:
576 Chapter | 18 Pituitary Function
- Page 575 and 576:
578 Chapter | 18 Pituitary Function
- Page 577 and 578:
580 Chapter | 18 Pituitary Function
- Page 579 and 580:
582 Chapter | 18 Pituitary Function
- Page 581 and 582:
584 Chapter | 18 Pituitary Function
- Page 583 and 584:
586 Chapter | 18 Pituitary Function
- Page 585 and 586:
588 Chapter | 18 Pituitary Function
- Page 587 and 588:
590 Chapter | 18 Pituitary Function
- Page 589 and 590:
592 Chapter | 18 Pituitary Function
- Page 591 and 592:
594 Chapter | 18 Pituitary Function
- Page 593 and 594:
596 Chapter | 18 Pituitary Function
- Page 595 and 596:
598 Chapter | 18 Pituitary Function
- Page 597 and 598:
600 Chapter | 18 Pituitary Function
- Page 599 and 600:
602 Chapter | 18 Pituitary Function
- Page 601 and 602:
604 Chapter | 18 Pituitary Function
- Page 603 and 604:
606 Chapter | 19 Adrenocortical Fun
- Page 605 and 606:
608 Chapter | 19 Adrenocortical Fun
- Page 607 and 608:
610 Chapter | 19 Adrenocortical Fun
- Page 609 and 610:
612 Chapter | 19 Adrenocortical Fun
- Page 611 and 612:
614 Chapter | 19 Adrenocortical Fun
- Page 613 and 614:
616 Chapter | 19 Adrenocortical Fun
- Page 615 and 616:
618 Chapter | 19 Adrenocortical Fun
- Page 617 and 618:
620 Chapter | 19 Adrenocortical Fun
- Page 619 and 620:
622 Chapter | 19 Adrenocortical Fun
- Page 621 and 622:
624 Chapter | 20 Thyroid Function a
- Page 623 and 624:
626 Chapter | 20 Thyroid Function t
- Page 625 and 626:
628 Chapter | 20 Thyroid Function A
- Page 627 and 628:
630 Chapter | 20 Thyroid Function S
- Page 629 and 630:
632 Chapter | 20 Thyroid Function a
- Page 631 and 632:
634 Chapter | 20 Thyroid Function O
- Page 633 and 634:
636 Chapter | 21 Clinical Reproduct
- Page 635 and 636:
638 Chapter | 21 Clinical Reproduct
- Page 637 and 638:
640 Chapter | 21 Clinical Reproduct
- Page 639 and 640:
642 Chapter | 21 Clinical Reproduct
- Page 641 and 642:
644 Chapter | 21 Clinical Reproduct
- Page 643 and 644:
646 Chapter | 21 Clinical Reproduct
- Page 645 and 646:
648 Chapter | 21 Clinical Reproduct
- Page 647 and 648:
650 Chapter | 21 Clinical Reproduct
- Page 649 and 650:
652 Chapter | 21 Clinical Reproduct
- Page 651 and 652:
654 Chapter | 21 Clinical Reproduct
- Page 653 and 654:
656 Chapter | 21 Clinical Reproduct
- Page 655 and 656:
658 Chapter | 21 Clinical Reproduct
- Page 657 and 658:
660 Chapter | 21 Clinical Reproduct
- Page 659 and 660:
662 Chapter | 21 Clinical Reproduct
- Page 661 and 662:
664 Chapter | 22 Trace Minerals the
- Page 663 and 664:
666 Chapter | 22 Trace Minerals the
- Page 665 and 666:
668 Chapter | 22 Trace Minerals P i
- Page 667 and 668:
670 Chapter | 22 Trace Minerals be
- Page 669 and 670:
Copper Cuproreductase Cytochromes C
- Page 671 and 672:
674 Chapter | 22 Trace Minerals 2 .
- Page 673 and 674:
676 Chapter | 22 Trace Minerals Cor
- Page 675 and 676:
678 Chapter | 22 Trace Minerals inf
- Page 677 and 678:
680 Chapter | 22 Trace Minerals tis
- Page 679 and 680:
682 Chapter | 22 Trace Minerals VI
- Page 681 and 682:
684 Chapter | 22 Trace Minerals red
- Page 683 and 684:
686 Chapter | 22 Trace Minerals of
- Page 685 and 686:
688 Chapter | 22 Trace Minerals Per
- Page 687 and 688:
690 Chapter | 22 Trace Minerals In
- Page 689 and 690:
692 Chapter | 22 Trace Minerals Liu
- Page 691 and 692:
Chapter 23 Vitamins Robert B. Rucke
- Page 693 and 694:
III. Fat-Soluble Vitamins 697 TABLE
- Page 695 and 696:
III. Fat-Soluble Vitamins 699 Carot
- Page 697 and 698:
III. Fat-Soluble Vitamins 701 Major
- Page 699 and 700:
III. Fat-Soluble Vitamins 703 doses
- Page 701 and 702:
III. Fat-Soluble Vitamins 705 Diet
- Page 703 and 704:
III. Fat-Soluble Vitamins 707 conta
- Page 705 and 706:
III. Fat-Soluble Vitamins 709 immun
- Page 707 and 708:
IV. Water-Soluble Vitamins 711 are
- Page 709 and 710:
IV. Water-Soluble Vitamins 713 abil
- Page 711 and 712:
IV. Water-Soluble Vitamins 715 5’
- Page 713 and 714:
IV. Water-Soluble Vitamins 717 H 2
- Page 715 and 716:
IV. Water-Soluble Vitamins 719 Enzy
- Page 718 and 719:
722 Chapter | 23 Vitamins When biot
- Page 720 and 721:
724 Chapter | 23 Vitamins Cyanocoba
- Page 722 and 723:
726 Chapter | 23 Vitamins V . VITAM
- Page 724 and 725:
728 Chapter | 23 Vitamins nature, r
- Page 726 and 727:
730 Chapter | 23 Vitamins Stites ,
- Page 728 and 729:
732 Chapter | 24 Lysosomal Storage
- Page 730 and 731:
734 Chapter | 24 Lysosomal Storage
- Page 732 and 733:
736 Chapter | 24 Lysosomal Storage
- Page 734 and 735:
738 Chapter | 24 Lysosomal Storage
- Page 736 and 737:
740 Chapter | 24 Lysosomal Storage
- Page 738 and 739:
742 Chapter | 24 Lysosomal Storage
- Page 740 and 741:
744 Chapter | 24 Lysosomal Storage
- Page 742 and 743:
746 Chapter | 24 Lysosomal Storage
- Page 744 and 745:
748 Chapter | 24 Lysosomal Storage
- Page 746 and 747:
Chapter 25 Tumor Markers Michael D.
- Page 748 and 749:
II. Serum Tumor Markers 753 also be
- Page 750 and 751:
III. Flow Cytometry 755 cancer of t
- Page 752 and 753:
V. Immunohistochemistry/Immunocytoc
- Page 754 and 755:
V. Immunohistochemistry/Immunocytoc
- Page 756 and 757:
References 761 analysis will facili
- Page 758 and 759:
References 763 Fernandez , N. J. ,
- Page 760 and 761:
References 765 Meinecke , B. , and
- Page 762 and 763:
References 767 Walter , J. ( 2000 )
- Page 764 and 765:
770 Chapter | 26 Cerebrospinal Flui
- Page 766 and 767:
772 Chapter | 26 Cerebrospinal Flui
- Page 768 and 769:
774 Chapter | 26 Cerebrospinal Flui
- Page 770 and 771:
776 Chapter | 26 Cerebrospinal Flui
- Page 772 and 773:
778 Chapter | 26 Cerebrospinal Flui
- Page 774 and 775:
TABLE 26-7 Continued Constituent Ro
- Page 776 and 777:
782 Chapter | 26 Cerebrospinal Flui
- Page 778 and 779:
784 Chapter | 26 Cerebrospinal Flui
- Page 780 and 781:
786 Chapter | 26 Cerebrospinal Flui
- Page 782 and 783:
788 Chapter | 26 Cerebrospinal Flui
- Page 784 and 785:
790 Chapter | 26 Cerebrospinal Flui
- Page 786 and 787:
792 Chapter | 26 Cerebrospinal Flui
- Page 788 and 789:
794 Chapter | 26 Cerebrospinal Flui
- Page 790 and 791:
796 Chapter | 26 Cerebrospinal Flui
- Page 792 and 793:
798 Chapter | 26 Cerebrospinal Flui
- Page 794 and 795:
800 Chapter | 26 Cerebrospinal Flui
- Page 796 and 797:
802 Chapter | 26 Cerebrospinal Flui
- Page 798 and 799:
804 Chapter | 26 Cerebrospinal Flui
- Page 800 and 801:
806 Chapter | 26 Cerebrospinal Flui
- Page 802 and 803:
808 Chapter | 26 Cerebrospinal Flui
- Page 804 and 805:
810 Chapter | 26 Cerebrospinal Flui
- Page 806 and 807:
812 Chapter | 26 Cerebrospinal Flui
- Page 808 and 809:
814 Chapter | 26 Cerebrospinal Flui
- Page 810 and 811:
816 Chapter | 26 Cerebrospinal Flui
- Page 812 and 813:
818 Chapter | 26 Cerebrospinal Flui
- Page 814 and 815:
Chapter 27 Clinical Biochemistry in
- Page 816 and 817:
II. Hepatotoxicity 823 Therefore, A
- Page 818 and 819:
III. Nephrotoxicity 825 suggested a
- Page 820 and 821:
IV. Toxins Affecting Skeletal and C
- Page 822 and 823:
VII. Toxins Affecting Erythrocytes
- Page 824 and 825:
VIII. Toxins Affecting Hemoglobin a
- Page 826 and 827:
IX. Toxins Affecting the Nervous Sy
- Page 828 and 829:
References 835 Plants classified as
- Page 830 and 831:
References 837 Solaiman , S. G. , M
- Page 832 and 833:
840 Chapter | 28 Avian Clinical Bio
- Page 834 and 835:
842 Chapter | 28 Avian Clinical Bio
- Page 836 and 837:
844 Chapter | 28 Avian Clinical Bio
- Page 838 and 839:
846 Chapter | 28 Avian Clinical Bio
- Page 840 and 841:
848 Chapter | 28 Avian Clinical Bio
- Page 842 and 843:
850 Chapter | 28 Avian Clinical Bio
- Page 844 and 845:
Budgerigar ALAT (IU/g tissue) Budge
- Page 846 and 847:
854 Chapter | 28 Avian Clinical Bio
- Page 848 and 849:
856 Chapter | 28 Avian Clinical Bio
- Page 850 and 851:
858 Chapter | 28 Avian Clinical Bio
- Page 852 and 853:
860 Chapter | 28 Avian Clinical Bio
- Page 854 and 855:
862 Chapter | 28 Avian Clinical Bio
- Page 856 and 857:
864 Chapter | 28 Avian Clinical Bio
- Page 858 and 859:
866 Chapter | 28 Avian Clinical Bio
- Page 860 and 861:
868 Chapter | 28 Avian Clinical Bio
- Page 862 and 863:
870 Chapter | 28 Avian Clinical Bio
- Page 864 and 865:
872 Chapter | 28 Avian Clinical Bio
- Page 866 and 867:
874 Appendix | I SI Units TABLE E S
- Page 868 and 869:
Appendix II Conversion Factors of S
- Page 870 and 871:
Appendix IV Stability of Serum Enzy
- Page 872 and 873:
Appendix VI Nomogram for Computing
- Page 874 and 875:
t0100 Appendix VIII Blood Analyte R
- Page 876 and 877:
884 Appendix | VIII Blood Analyte R
- Page 878 and 879:
886 Appendix | VIII Blood Analyte R
- Page 880 and 881:
888 Appendix | VIII Blood Analyte R
- Page 882 and 883:
890 Appendix | IX Blood Analyte Ref
- Page 884 and 885:
892 Appendix | IX Blood Analyte Ref
- Page 886 and 887:
894 Appendix | IX Blood Analyte Ref
- Page 888 and 889:
Appendix X Blood Analyte Reference
- Page 890 and 891:
Appendix XI Blood Analyte Reference
- Page 892 and 893:
Appendix XII Urine Analyte Referenc
- Page 894 and 895:
902 Appendix | XIII Cerebrospinal F
- Page 896:
904 Appendix | XIV Cerebrospinal Fl